Search Results - Steve Kwilas

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates

    A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates by Steve Kwilas, Jennifer M. Kishimori, Matthew Josleyn, Kurt Jerke, John Ballantyne, Michael Royals, Jay W. Hooper

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure

    Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure by Nicole N. Haese, Rebecca L. Brocato, Thomas D. Henderson, Matthew L. Nilles, Steve Kwilas, Matthew Josleyn, Christopher Hammerbeck, James Schiltz, Michael Royals, John Ballantyne, Jay W. Hooper, David S. Bradley

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice

    Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice by Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman, Ye Liu, David C. Flyer, Michael J. Massare, Ren-Huan Xu, Bin Zhou, Hanxin Lu, Steve Kwilas, Timothy Hahn, Eloi Kpamegan, Jay W. Hooper, Ricardo Carrion, Gregory M. Glenn, Gale Smith

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses

    Preclinical Development of Inactivated Rabies Virus–Based Polyvalent Vaccine Against Rabies and Filoviruses by Mallory Willet, Drishya Kurup, Amy B. Papaneri, Christoph Wirblich, Jay W. Hooper, Steve Kwilas, Rohan Keshwara, Andrew W. Hudacek, Stefanie Beilfuß, Grit Rudolph, E. Pommerening, Adriaan Vos, Andreas Neubert, Peter B. Jahrling, Joseph E. Blaney, Reed F. Johnson, Matthias J. Schnell

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

    The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial by Angela Huttner, Julie-Anne Dayer, Sabine Yerly, Christophe Combescure, Floriane Auderset, Jules Desmeules, Markus Eickmann, Axel Finckh, Ana Rita Gonçalves, Jay W. Hooper, Gürkan Kaya, Verena Krähling, Steve Kwilas, Barbara Lemaître, Alain Matthey, Peter Silvera, Stephan Becker, Patricia Fast, Vasee Moorthy, Marie Paule Kiény, Laurent Kaiser, Claire‐Anne Siegrist

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle

    Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle by John M. Dye, Hua Wu, Jay W. Hooper, Surender Khurana, Ana I. Kuehne, Elizabeth M. Coyle, Ramon A. Ortiz, Sandra Fuentes, Andrew S. Herbert, Hana Golding, Russell A. Bakken, Jennifer M. Brannan, Steve Kwilas, Eddie J. Sullivan, Thomas Luke, Gale Smith, Gregory M. Glenn, Wenfang Li, Ling Ye, Chinglai Yang, Richard W. Compans, Ralph A. Tripp, Jin‐an Jiao

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: